Ovid Therapeutics OVID
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.63 | -127.20 | 0.14 | -12,293 | 10 | |
| 2025Q3 | 1.30 | 103.00 | -0.16 | -12,523 | -12 | |
| 2025Q2 | 0.33 | 108.30 | -0.06 | -5,073 | -5 | |
| 2025Q1 | 0.31 | 122.62 | -0.14 | -12,550 | -10 | |
| 2024Q4 | 0.93 | 115.88 | -0.13 | -10,722 | -9 | |
| 2024Q3 | 1.18 | 94.45 | -0.20 | -13,229 | -14 | |
| 2024Q2 | 0.77 | -240.81 | 0.13 | -20,517 | 9 | |
| 2024Q1 | 3.05 | 148.94 | -0.17 | -17,417 | -12 | |
| 2023Q4 | 3.22 | 118.71 | -0.21 | -18,188 | -15 | |
| 2023Q3 | 3.84 | 106.90 | -0.15 | -12,029 | -11 | |
| 2023Q2 | 3.28 | 114.22 | -0.18 | -14,172 | -12 | |
| 2023Q1 | 2.58 | 111.50 | -0.19 | -14,892 | -13 | |
| 2022Q4 | 1.86 | 105.81 | -0.16 | -12,173 | -12 | |
| 2022Q3 | 1.84 | 106.99 | -0.17 | -12,804 | -12 | |
| 2022Q2 | 2.15 | 97.72 | -0.21 | -14,304 | -15 | |
| 2022Q1 | 3.14 | 101.30 | 1.80 | -0.23 | -16,267 | -16 |
| 2021Q4 | 3.21 | 100.02 | 1.72 | -0.38 | -26,354 | -26 |
| 2021Q3 | 3.36 | 100.03 | 1.87 | -0.16 | -11,682 | -11 |
| 2021Q2 | 3.91 | 99.98 | 2.31 | -0.23 | -14,313 | -16 |
| 2021Q1 | 4.02 | 100.03 | 2.53 | 176,557 | 176 |